Skip to main content

Advertisement

Log in

Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Although the association between anemia and cardiovascular mortality in hemodialysis patients is well established, whether hemoglobin variability (Hgb-Var) affects the prognosis remains unclear. We aimed to evaluate the association between Hgb-Var and cardiovascular mortality in Chinese hemodialysis patients.

Methods

This retrospective study included 252 patients starting hemodialysis in Xin Hua Hospital between January 2009 and December 2015. Patients were divided into three tertiles based on Hgb-Var, as reflected by SD Hgbmean, SD Hgbrange, and Hgbdeflection during a 12-month evaluation period after hemodialysis initiation. Left ventricular ejection fraction (EF) and left ventricular mass index (LVMI) were evaluated by echocardiography. Information on cardiovascular deaths occurred by December 2017 was collected. Multivariate Cox regression models were constructed to evaluate the association between Hgb-Var and cardiovascular mortality.

Results

A total of 75 deaths and 52 cardiovascular deaths occurred during the 47-month follow-up (range 29.5–70). Under multivariate regression, the subgroup with the highest Hgb-Var had a higher risk of cardiovascular mortality after adjusting for relevant factors (HR vs. lowest SD Hgbmean: 9.15, 95% CI 2.82, 29.693, P < 0.0001; HR vs. lowest SD Hgbrange: 3.81, 95% CI 1.40, 10.38, P = 0.005). Per 1 SD of Hgbmean and Hgbrange elevations were both related to a 10% increase in the cardiovascular mortality risk. Baseline EF% and LVMI did not differ across the Hgb-Var subgroups. EF% upon the last patient visit to the clinic was lower in the subgroup with the highest SD Hgbmean (P = 0.02).

Conclusions

High Hgb-Var is an independent risk factor for cardiovascular mortality in hemodialysis patients and might influence the cardiac function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53–61

    Article  PubMed  CAS  Google Scholar 

  2. Eckardt KU (2005) Managing a fateful alliance: anaemia and cardiovascular outcomes. Nephrol Dial Transplant 20(Suppl 6):vi16–20

    Article  PubMed  Google Scholar 

  3. Ebben JP, Gilbertson DT, Foley RN, Collins AJ (2006) Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 1:1205–1210

    Article  PubMed  Google Scholar 

  4. Eckardt KU, Scherhag A, Macdougall IC, Tsakiris D, Clyne N, Locatelli F, Zaug MF, Burger HU, Drueke TB (2009) Left Ventricular Geometry Predicts Cardiovascular Outcomes Associated with Anemia Correction in CKD. J Am Soc Nephrol 20:2651–2660

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P (2009) Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis. Clin J Am Soc Nephrol 4:755–762

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 16:233–271

    Article  PubMed  Google Scholar 

  7. Yang W, Israni RK, Brunelli SM, Joffe MM, Fishbane S, Feldman HI (2007) Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol 18:3164–3170

    Article  PubMed  CAS  Google Scholar 

  8. Members AF, Mancia G, De Backer G et al (2006) 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28:1462–1536

    Article  Google Scholar 

  9. McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL (2016) Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease. Am J Kidney Dis 68:S5–S14

    Article  PubMed  Google Scholar 

  10. Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ (2011) Hemoglobin variability and mortality: confounding by disease severity. Am J Kidney Dis 57:255–265

    Article  PubMed  CAS  Google Scholar 

  11. Lau JH, Gangji AS, Rabbat CG, Brimble KS (2010) Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial. Nephrol Dial Transplant 25:4002–4009

    Article  PubMed  CAS  Google Scholar 

  12. Altunoren O, Dogan E, Sayarlioglu H, Acar G, Yavuz YC, Aydın N, Sahin M, Akkoyun M, Isik IO, Altunoren O (2013) Effect of hemoglobin variability on mortality and some cardiovascular parameters in hemodialysis patients. Ren Fail 35:819–824

    Article  PubMed  CAS  Google Scholar 

  13. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458

    Article  PubMed  CAS  Google Scholar 

  14. Boudville NC, Djurdjev O, Macdougall IC, de Francisco AL, Deray G, Besarab A, Stevens PE, Walker RG, Ureña P, Iñigo P, Minutolo R, Haviv YS, Yeates K, Agüera ML, MacRae JM, Levin A (2009) Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality. Clin J Am Soc Nephrol 4:1176–1182

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Brunelli SM, Joffe MM, Israni RK, Yang W, Fishbane S, Berns JS, Feldman HI (2008) History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol 3:777–782

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ (2008) Hemoglobin level variability: associations with mortality. Clin J Am Soc Nephrol 3:133–138

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Eckardt KU, Kim J, Kronenberg F, Aljama P, Anker SD, Canaud B, Molemans B, Stenvinkel P, Schernthaner G, Ireland E, Fouqueray B, Macdougall IC (2010) Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol 21:1765–1775

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Fishbane S, Berns JS (2005) Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68:1337–1343

    Article  PubMed  CAS  Google Scholar 

  19. Kalantar-Zadeh K, Aronoff GR (2009) Hemoglobin variability in anemia of chronic kidney disease. J Am Soc Nephrol 20:479–487

    Article  PubMed  CAS  Google Scholar 

  20. Singh AK (2010) The FDA’s perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo vadis. Clin J Am Soc Nephrol 5:553–556

    Article  PubMed  Google Scholar 

  21. Noordzij M, Jager KJ (2014) Increased mortality early after dialysis initiation: a universal phenomenon. Kidney Int 85:12–14

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Grant No. 81500507) and Young Investigator Scholarship of Xin Hua Hospital (Grant No. 2015001).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xin Zhou or Wei Lu.

Ethics declarations

Conflict of interest

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, FJ., Zhang, X., Huang, LS. et al. Impact of hemoglobin variability on cardiovascular mortality in maintenance hemodialysis patients. Int Urol Nephrol 50, 1703–1712 (2018). https://doi.org/10.1007/s11255-018-1919-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-018-1919-5

Keywords

Navigation